Surgical Endoscopy

, Volume 31, Issue 8, pp 3227–3233 | Cite as

Routine staging with endoscopic ultrasound in patients with obstructing esophageal cancer and dysphagia rarely impacts treatment decisions

  • Sara A. Mansfield
  • Samer El-Dika
  • Somashekar G. Krishna
  • Kyle A. Perry
  • Jon P. Walker



Endoscopic ultrasound (EUS) has been routinely utilized for the locoregional staging of esophageal cancer. One important aspect of clinical staging has been to stratify patients to treatment with neoadjuvant chemoradiation or primary surgical therapy. We hypothesized that EUS may have a limited impact on clinical decision making in patients with dysphagia and obstructing esophageal masses.


This retrospective cohort study included all patients with esophageal adenocarcinoma undergoing esophageal EUS between July 2008 and September 2013. Dysplastic Barrett’s esophagus without invasive adenocarcinoma or incomplete staging was excluded. Patient demographics, endoscopic tumor characteristics, the presence of dysphagia, sonographic staging, and post-EUS therapy were recorded. Pathologic staging for patients who underwent primary surgical therapy was also recorded. Locally advanced disease was defined as at least T3 or N1, as these patients are typically treated with neoadjuvant therapy.


Two hundred sixteen patients underwent EUS for esophageal adenocarcinoma, with 147 (68.1%) patients having symptoms of dysphagia on initial presentation. Patients with dysphagia were significantly more likely to have locally advanced disease on EUS than patients without dysphagia (p < 0.0001). Additionally, 145 (67.1%) patients had a partially or completely obstructing mass on initial endoscopy, of which 136 (93.8%) were locally advanced (p < 0.0001 vs. non-obstructing lesions).


An overwhelming majority of patients presenting with dysphagia and/or the presence of at least partially obstructing esophageal mass at the time of esophageal cancer diagnosis had an EUS that demonstrated at least locally advanced disease. The present study supports the hypothesis that EUS may be of limited benefit for management of esophageal cancer in patients with an obstructing mass and dysphagia.


Endoscopic ultrasound Esophageal cancer Dysphagia Staging 



Research reported in this publication was supported by the National Institutes of Health Awards T32-CA090223.

Author contributions

SAM, KAP, and JPW were involved in study conception and design. SAM, SE-D, SGK, KAP, and JPW acquired the data. SAM, SE-D, SGK, KAP, and JPW analyzed and interpreted the data. SAM, KAP, and JPW drafted the manuscript. SAM, SE-D, SGK, KAP, and JPW critically revised the manuscript for important intellectual content. SAM, and KAP performed all the statistical analyses.

Compliance with ethical standards


Sara A. Mansfield, Samer El-Dika, Somashekar G. Krishna, Kyle A. Perry, and Jon P. Walker have no conflicts of interest or financial ties to disclose.


  1. 1.
    Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184–1187CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H, National comprehensive cancer network (2015) Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Cancer Netw 13:194–227CrossRefGoogle Scholar
  3. 3.
    Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, Hoffman BJ, Reed CE (2002) An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg 74:1026–1032CrossRefPubMedGoogle Scholar
  4. 4.
    Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR (2008) Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol 14:1479CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, Bansal A, Yen R, Hosford L, Jankowski M, Sharma P (2015) Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study. Cancer 121:194–201CrossRefPubMedGoogle Scholar
  6. 6.
    Mariette C, Balon JM, Maunoury V, Taillier G, Van Seuningen I, Triboulet JP (2003) Value of endoscopic ultrasonography as a predictor of long-term survival in esophageal carcinoma. Br J Surg 90:1367–1372CrossRefPubMedGoogle Scholar
  7. 7.
    Worrell SG, Oh DS, Greene CL, Demeester SR, Hagen JA (2014) Endoscopic ultrasound staging of stenotic esophageal cancers may be unnecessary to determine the need for neoadjuvant therapy. J Gastrointest Surg 18:318–320CrossRefPubMedGoogle Scholar
  8. 8.
    Heile M, De Leyn P, Schurmans P, Lerut A, Huys S, Geboes K, Gevers AM, Rutgeerts P (1997) Relation between endoscopic ultrasound findings and outcome of patients with tumors of the esophagus or esophagogastric junction. Gastrointest Endosc 45:381–386CrossRefGoogle Scholar
  9. 9.
    Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, Adusumilli PS, Huang J, Finley DJ, Rusch VW, Rizk NP (2016) Pretreatment dysphagia in esophageal cancer patients may eliminate the need for staging by endoscopic ultrasonography. Ann Thorac Surg 101(1):226–230CrossRefPubMedGoogle Scholar
  10. 10.
    Fang TC, Oh YS, Szabo A, Khan A, Dua KS (2015) Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer. Dis Esophagus. doi: 10.1111/dote.12394 Google Scholar
  11. 11.
    Lee G, Hoseok I, Kim SJ, Jeong YJ, Kim IJ, Pak K, Park DY, Kim GH (2014) Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT. J Nucl Med 55:1242–1247CrossRefPubMedGoogle Scholar
  12. 12.
    Ribeiro A, Franceschi D, Parra J, Livingstone A, Lima M, Hamilton-Nelson K, Ardalan B (2006) Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol 101:1216–1221CrossRefPubMedGoogle Scholar
  13. 13.
    Griffin JM, Reed CE, Denlinger CE (2012) Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer. Ann Thorac Surg 93(6):1855–1859CrossRefPubMedGoogle Scholar
  14. 14.
    Bhutani MS, Barde CJ, Markert RJ, Gopalswamy N (2002) Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound. Endoscopy 34:461–463CrossRefPubMedGoogle Scholar
  15. 15.
    Morgan MA, Twine CP, Lewis WG, Lambe R, Oliphant HE, Robinson M, Crosby TD, Roberts SA (2008) Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound. Dis Esophagus 21:508–513CrossRefPubMedGoogle Scholar
  16. 16.
    Van Dam J, Rice TW, Catalano MF, Kriby T, Sivak MV Jr (1993) High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 71:2910–2917CrossRefPubMedGoogle Scholar
  17. 17.
    Jacobson BC, Shami VM, Faigel DO, Larghi A, Kahaleh M, Dye C, Pedrosa M, Waxman I (2007) Through-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancer. Dig Dis Sci 52:817–822CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jenssen C, Alvarez-Sánchez MV, Napoléon B, Faiss S (2012) Diagnostic endoscopic ultrasonography: assessment of safety and prevention of complications. World J Gastroenterol 18:4659–4676CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Das A, Sivak MV Jr, Chak A (2001) Cervical esophageal perforation during EUS: a national survey. Gastrointest Endosc 53:599–602CrossRefPubMedGoogle Scholar
  20. 20.
    Findlay JM, Bradley KM, Maile EJ, Braden B, Maw J, Phillips-Hughes J, Gillies RS, Maynard ND, Middleton MR (2015) Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy. Br J Surg 102(12):1488–1499CrossRefPubMedGoogle Scholar
  21. 21.
    Tekola BD, Sauer BG, Wang AY, White GE, Shami VM (2014) Accuracy of endoscopic ultrasound in the diagnosis of T2N0 esophageal cancer. J Gastrointest Cancer 45:342–346CrossRefPubMedGoogle Scholar
  22. 22.
    Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL (2014) Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol 9:1202–1206CrossRefPubMedGoogle Scholar
  23. 23.
    Bergeron EJ, Lin J, Chang AC, Orringer MB, Reddy RM (2014) Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies. J Thorac Cardiovasc Surg 147:765–771CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Sara A. Mansfield
    • 1
  • Samer El-Dika
    • 2
  • Somashekar G. Krishna
    • 2
  • Kyle A. Perry
    • 1
  • Jon P. Walker
    • 2
  1. 1.General and Gastrointestinal SurgeryThe Ohio State University Wexner Medical CenterColumbusUSA
  2. 2.Section of Advanced Endoscopy, Division of Gastroenterology, Hepatology and Nutrition, Department of Internal MedicineThe Ohio State University Wexner Medical CenterColumbusUSA

Personalised recommendations